-
1
المؤلفون: Xiaoyun Li, Cathy Anne Pinto, Emilie Scherrer, Mizuho Kalabis, Xinyue Liu
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, Combination therapy, business.industry, medicine.medical_treatment, Medical record, Disease progression, Pembrolizumab, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, Stable Disease, Internal medicine, medicine, Nivolumab, business, Social Security Death Index
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a08aa4a18c0690b927dab1976b7af3Test
https://doaj.org/article/1bfc61267f7a45059e87b4fee703575bTest -
2
المؤلفون: Daniela E. Myers, Lawrence F. Eichenfield, Mizuho Kalabis, Linda Stein Gold, Paul Sanders, Chuanbo Zang, Gil Yosipovitch, Joseph C. Cappelleri, Andrew G. Bushmakin, Melissa Olivadoti, Amy S. Paller, Bonnie Vlahos
المصدر: Pediatric Dermatology
مصطلحات موضوعية: Boron Compounds, medicine.medical_specialty, Adolescent, Dermatology, Severity of Illness Index, Dermatitis, Atopic, Ointments, 030207 dermatology & venereal diseases, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Disease severity, Double-Blind Method, Phosphodiesterase 4 Inhibitor, Internal medicine, Post-hoc analysis, medicine, Humans, Child, Nonsteroidal, atopic dermatitis, business.industry, Pruritus, therapy‐topical, Crisaborole, Atopic dermatitis, Original Articles, medicine.disease, Bridged Bicyclo Compounds, Heterocyclic, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Child, Preschool, Pediatrics, Perinatology and Child Health, Original Article, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952ff611dd5cbeb0967aa859501efed0Test
https://pubmed.ncbi.nlm.nih.gov/32981097Test -
3
المؤلفون: Evan J. Lipson, Ragini R. Kudchadkar, Sunil Reddy, Tomoko Akaike, Thomas Olencki, William H. Sharfman, Philip Friedlander, Steven P. Fling, Mizuho Kalabis, Candice D. Church, Kari Kendra, Michi M. Shinohara, Adil Daud, Adam I. Riker, Harriet M. Kluger, Elad Sharon, Melissa Amber Burgess, Janis M. Taube, Paul Nghiem, Brent A. Hanks, Suzanne L. Topalian, Blanca Homet Moreno, Andrew S. Brohl, Brian C. Boulmay, Martin A. Cheever, Bob Salim, Erin Jensen, Shailender Bhatia, Nirasha Ramchurren
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for immunotherapy of cancer, vol 9, iss 4
Journal for Immunotherapy of Cancerمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Stable Disease, Cancer immunotherapy, Monoclonal, 80 and over, Immunology and Allergy, Humanized, Immune Checkpoint Inhibitors, 6.2 Cellular and gene therapies, RC254-282, Cancer, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Merkel cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, medicine.medical_specialty, Clinical Trials and Supportive Activities, Immunology, Antibodies, Monoclonal, Humanized, Antibodies, 03 medical and health sciences, Clinical Research, Internal medicine, medicine, Humans, Neoplasm Staging, Aged, Salvage Therapy, Pharmacology, Chemotherapy, business.industry, Carcinoma, Evaluation of treatments and therapeutic interventions, Immunotherapy, medicine.disease, Carcinoma, Merkel Cell, 030104 developmental biology, Tumor progression, Merkel Cell, Skin cancer, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272adca2addf0d58650483b69b745a95Test
https://doi.org/10.1136/jitc-2021-002478Test -
4
المؤلفون: Elliot Chartash, Lokesh Jain, Dinesh P. de Alwis, Mallika Lala, Shu-Chih Su, Omobolaji Oyekunle Akala, Mizuho Kalabis, Vikram Sinha
المصدر: Cancer Research. 80:CT042-CT042
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Clinical trial, 03 medical and health sciences, Regimen, 030104 developmental biology, 0302 clinical medicine, Pharmacokinetics, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Every Three Weeks, media_common.cataloged_instance, Dosing, European union, business, media_common
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1d8ef5ccc60934dcfca3fe1cc81b3fcfTest
https://doi.org/10.1158/1538-7445.am2020-ct042Test -
5
المؤلفون: Nicholas J. Petrelli, Michela Perego, Marilda Beqiri, Mizuho Kalabis, Denitsa Hristova, Rajasekharan Somasundaram, Min Xiao, Clemens Krepler, Meenhard Herlyn
المصدر: Clinical Cancer Research. 22:PR02-PR02
مصطلحات موضوعية: Genetically modified mouse, Cancer Research, biology, business.industry, Melanoma, medicine.disease, Immune checkpoint, Immune system, Oncology, Antigen, Immunology, Humanized mouse, biology.protein, Medicine, Antibody, business, Immunodeficient Mouse
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8d0506b5ced6fd89f03d0cb8c5ceeff4Test
https://doi.org/10.1158/1557-3265.pdx16-pr02Test